Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09NTG
|
||||
Former ID |
DNC003471
|
||||
Drug Name |
Taurocholic Acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 1/2 | [467784] | ||
Structure |
Download2D MOL |
||||
Formula |
C26H45NO7S
|
||||
InChI |
InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1
|
||||
InChIKey |
WBWWGRHZICKQGZ-HZAMXZRMSA-N
|
||||
CAS Number |
CAS 81-24-3
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
86672, 605316, 828139, 841389, 4266393, 8138084, 8154316, 14717827, 15805741, 17422067, 29225628, 47439969, 49748546, 50065243, 50397873, 53789715, 57323632, 92309274, 93167213, 103512877, 104312745, 119526221, 125311155, 125311164, 134972658, 135750992, 137102321, 137202600, 138724705, 144080928, 160854684, 162224002, 163138205, 164779365, 176484548, 178101267, 178101268, 179323898, 198948969, 224772447, 226395830, 252497719
|
||||
Target and Pathway | |||||
Target(s) | Bile-salt-activated lipase | Target Info | Inhibitor | [551393] | |
BioCyc Pathway | Triacylglycerol degradation | ||||
WikiPathways | Lipid digestion, mobilization, and transport | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.